| NCT02593773 |
Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich’s Ataxia Study |
https://ClinicalTrials.gov/show/NCT02593773 |
Completed |
Horizon Pharma Ireland, Ltd., Dublin Ireland |
2017-03-21 |
| NCT03347344 |
Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL) |
https://ClinicalTrials.gov/show/NCT03347344 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2019-01-17 |
| NCT03202771 |
Randomized Controlled Trial of Home Versus Office Biofeedback for Constipation |
https://ClinicalTrials.gov/show/NCT03202771 |
Completed |
Augusta University |
2010-12-31 |
| NCT03120013 |
Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia |
https://ClinicalTrials.gov/show/NCT03120013 |
Completed |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2018-12-01 |
| NCT03109626 |
Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38 |
https://ClinicalTrials.gov/show/NCT03109626 |
Completed |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2015-09-17 |
| NCT02977377 |
The Effects Of Whole Body Vibration On Postural Control In Patients With Ataxia |
https://ClinicalTrials.gov/show/NCT02977377 |
Completed |
Hacettepe University |
2017-10-31 |
| NCT02960893 |
Trial in Adult Subjects With Spinocerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT02960893 |
Active, not recruiting |
Biohaven Pharmaceuticals, Inc. |
2017-08-18 |
| NCT02900508 |
Virtual Reality-based Training in Cerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT02900508 |
Completed |
National Yang Ming University |
2015-07-31 |
| NCT02887703 |
Augmenting Balance in Individuals With Cerebellar Ataxias |
https://ClinicalTrials.gov/show/NCT02887703 |
Completed |
University of Michigan |
2018-01-31 |
| NCT02874911 |
Coordination Training With Complete Body Video Games in Children and Adults With Degenerative Ataxias |
https://ClinicalTrials.gov/show/NCT02874911 |
Completed |
University Hospital Tuebingen |
2014-09-30 |
| NCT02840669 |
A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich’s Ataxia (CARFA Study) |
https://ClinicalTrials.gov/show/NCT02840669 |
Completed |
Adverum Biotechnologies, Inc. |
2018-06-30 |
| NCT02797080 |
Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT02797080 |
Completed |
Horizon Pharma Ireland, Ltd., Dublin Ireland |
2017-03-31 |
| NCT02770807 |
EDS in Ataxia Telangiectasia Patients |
https://ClinicalTrials.gov/show/NCT02770807 |
Recruiting |
Erydel |
2020-11-30 |
| NCT02741440 |
Natural History of Spinocerebellar Ataxia Type 7 (SCA7) |
https://ClinicalTrials.gov/show/NCT02741440 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-01-01 |
| NCT02733679 |
Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone |
https://ClinicalTrials.gov/show/NCT02733679 |
Completed |
NHS Tayside |
2017-08-30 |
| NCT02705547 |
Rosuvastatin (Crestor) in Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT02705547 |
Completed |
Children’s Hospital of Philadelphia |
2017-08-04 |
| NCT02660112 |
(+) Epicatechin to Treat Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT02660112 |
Completed |
Mayo Clinic |
2018-12-30 |
| NCT04102501 |
A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT04102501 |
Recruiting |
Retrotope, Inc. |
2021-02-28 |
| NCT02488031 |
Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT02488031 |
Completed |
University of Florida |
2019-01-17 |
| NCT02445794 |
A First in Human Study of RT001 in Patients With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT02445794 |
Completed |
Retrotope, Inc. |
2016-06-30 |
| NCT02424435 |
Methylprednisolone Treatment of Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT02424435 |
Completed |
Children’s Hospital of Philadelphia |
2017-12-31 |
| NCT02353299 |
Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT02353299 |
Completed |
Currax Pharmaceuticals |
2016-01-31 |
| NCT02345200 |
Body Composition and Hormonal Status in Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT02345200 |
Completed |
Johann Wolfgang Goethe University Hospital |
2014-04-30 |
| NCT02345135 |
Susceptibility to Infections in Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT02345135 |
Completed |
Johann Wolfgang Goethe University Hospital |
2016-01-31 |
| NCT02333305 |
Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10 |
https://ClinicalTrials.gov/show/NCT02333305 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-09-30 |
| NCT02323243 |
Clinical Interest of the Temporary Urethral Stent Allium " Bulbar Urethral Stent " in the Treatment of Detrusor Sphincter Dyssynergia |
https://ClinicalTrials.gov/show/NCT02323243 |
Completed |
Hospices Civils de Lyon |
2016-05-31 |
| NCT02255435 |
RTA 408 Capsules in Patients With Friedreich’s Ataxia - MOXIe |
https://ClinicalTrials.gov/show/NCT02255435 |
Active, not recruiting |
Reata Pharmaceuticals, Inc. |
2019-10-03 |
| NCT04039048 |
Effect of ctDCS During Balance Training on Cerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT04039048 |
Recruiting |
Universidade Federal de Pernambuco |
2020-02-29 |
| NCT03917225 |
A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich’s Ataxia in Male and Female Patients |
https://ClinicalTrials.gov/show/NCT03917225 |
Active, not recruiting |
Minoryx Therapeutics, S.L. |
2020-03-31 |
| NCT01303406 |
Patient Reported Outcomes in Friedreich’s Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI) |
https://ClinicalTrials.gov/show/NCT01303406 |
Completed |
Santhera Pharmaceuticals |
2012-07-31 |
| NCT01307176 |
Exercise Training Program for Cerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT01307176 |
Completed |
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
2014-02-28 |
| NCT03879018 |
Retraining Reaching in Cerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT03879018 |
Recruiting |
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
2021-04-01 |
| NCT01983631 |
The Effect of Whole Body Vibration Training on Neuromuscular Property in Individuals With Ataxia |
https://ClinicalTrials.gov/show/NCT01983631 |
Completed |
Chang Gung University |
2013-03-31 |
| NCT01965327 |
Interferon Gamma-1b in Friedreich Ataxia (FRDA) |
https://ClinicalTrials.gov/show/NCT01965327 |
Completed |
Children’s Hospital of Philadelphia |
2014-03-31 |
| NCT01964664 |
Mindfulness Meditation for Subjects With Severe Speech and Physical Impairments |
https://ClinicalTrials.gov/show/NCT01964664 |
Completed |
Oregon Health and Science University |
2016-10-31 |
| NCT01898884 |
Safety and Pharmacology Study of VP 20629 in Adults With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT01898884 |
Completed |
Shire |
2015-06-18 |
| NCT01811706 |
Dalfampridine and Gait in Spinocerebellar Ataxias |
https://ClinicalTrials.gov/show/NCT01811706 |
Completed |
University of Florida |
2013-12-31 |
| NCT01728064 |
Safety and Efficacy of EPI-743 in Patients With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT01728064 |
Completed |
Edison Pharmaceuticals Inc |
2015-10-31 |
| NCT01716221 |
An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT01716221 |
Completed |
University of Colorado, Denver |
2013-03-31 |
| NCT04107740 |
C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration |
https://ClinicalTrials.gov/show/NCT04107740 |
Recruiting |
Chem Tech Research Incorporation |
2020-06-30 |
| NCT01649687 |
Treatment of Cerebellar Ataxia With Mesenchymal Stem Cells |
https://ClinicalTrials.gov/show/NCT01649687 |
Completed |
National Yang Ming University |
2014-01-31 |
| NCT03408080 |
An Open Pilot Trial of BHV-4157 |
https://ClinicalTrials.gov/show/NCT03408080 |
Active, not recruiting |
University of California, Los Angeles |
2021-04-30 |
| NCT01493973 |
Efficacy Study of Epoetin Alfa in Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT01493973 |
Completed |
Federico II University |
2014-10-31 |
| NCT00631202 |
Efficacy of Epoetin Alfa in Patients With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT00631202 |
Completed |
Federico II University |
2008-12-31 |
| NCT01350440 |
Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT01350440 |
Completed |
University of South Florida |
2013-07-31 |
| NCT01339884 |
A Study of Resveratrol as Treatment for Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT01339884 |
Completed |
Murdoch Childrens Research Institute |
2012-08-31 |
| NCT04428567 |
Treadmill Training in Fragile X-associated Tremor/Ataxia Syndrome |
https://ClinicalTrials.gov/show/NCT04428567 |
Recruiting |
Rush University Medical Center |
2021-07-30 |
| NCT04426149 |
Clinical Effects of Oral Trehalose In Patients With Spinocerebellar Ataxia 3 |
https://ClinicalTrials.gov/show/NCT04426149 |
Completed |
National University of Malaysia |
2018-09-07 |
| NCT04399265 |
Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3 |
https://ClinicalTrials.gov/show/NCT04399265 |
Recruiting |
National University of Malaysia |
2021-09-30 |
| NCT04183647 |
Investigation of Acute Effects of Local Vibration and Whole-Body Vibration Applications |
https://ClinicalTrials.gov/show/NCT04183647 |
Completed |
Hacettepe University |
2019-05-01 |
| NCT04176991 |
Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT04176991 |
Recruiting |
Larimar Therapeutics, Inc. |
2020-09-30 |
| NCT04153110 |
Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia |
https://ClinicalTrials.gov/show/NCT04153110 |
Recruiting |
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia |
2020-09-01 |
| NCT03972202 |
The Role of Cerebellum in Speech |
https://ClinicalTrials.gov/show/NCT03972202 |
Recruiting |
University of California, San Francisco |
2022-01-01 |
| NCT03945682 |
The ASsessment and Physiotherapy managEment of Ataxia in Children Following Surgical Resection of Posterior Fossa Tumour |
https://ClinicalTrials.gov/show/NCT03945682 |
Recruiting |
Alder Hey Children’s NHS Foundation Trust |
2020-12-31 |
| NCT03933163 |
Micronised Resveratrol as a Treatment for Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT03933163 |
Recruiting |
Murdoch Childrens Research Institute |
2020-12-31 |
| NCT03932669 |
Effect of Nilotinib in Cerebellar Ataxia Patients |
https://ClinicalTrials.gov/show/NCT03932669 |
Active, not recruiting |
Seoul National University Hospital |
2020-04-30 |
| NCT03901638 |
Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy |
https://ClinicalTrials.gov/show/NCT03901638 |
Recruiting |
National Taiwan University Hospital |
2021-11-15 |
| NCT03888664 |
Open Trail of γIFN for Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT03888664 |
Completed |
IRCCS Eugenio Medea |
2017-12-31 |
| NCT03817086 |
Physical and Mental Practice for Bimanual Coordination Rehabilitation |
https://ClinicalTrials.gov/show/NCT03817086 |
Recruiting |
Kessler Foundation |
2020-05-30 |
| NCT03759678 |
N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) |
https://ClinicalTrials.gov/show/NCT03759678 |
Recruiting |
IntraBio Inc |
2020-07-01 |
| NCT03745248 |
Aerobic Exercise, Balance Training, and Ataxia |
https://ClinicalTrials.gov/show/NCT03745248 |
Completed |
Columbia University |
2019-06-09 |
| NCT03703830 |
tDCS Associated With Locomotor Training on Functional Mobility of Cerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT03703830 |
Recruiting |
Universidade Federal de Pernambuco |
2020-01-31 |
| NCT03701776 |
Ataxia, Imaging, and Exercise Disease Using MRI and Gait Analysis |
https://ClinicalTrials.gov/show/NCT03701776 |
Recruiting |
Columbia University |
2021-06-30 |
| NCT03701399 |
Troriluzole in Adult Subjects With Spinocerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT03701399 |
Recruiting |
Biohaven Pharmaceuticals, Inc. |
2020-10-31 |
| NCT03687190 |
Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients |
https://ClinicalTrials.gov/show/NCT03687190 |
Completed |
Changhua Christian Hospital |
2015-12-02 |
| NCT03619772 |
EMG Training for Altering Activation Patterns After Stroke |
https://ClinicalTrials.gov/show/NCT03619772 |
Active, not recruiting |
Shirley Ryan AbilityLab |
2020-10-31 |
| NCT03607058 |
The Effects of Game Based Exercise Training on Balance and Postural Control in Patients With Ataxia |
https://ClinicalTrials.gov/show/NCT03607058 |
Recruiting |
Hacettepe University |
2018-09-30 |
| NCT03563053 |
Open-label, Long-term, Extension Treatment Using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients With Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study |
https://ClinicalTrials.gov/show/NCT03563053 |
Recruiting |
Erydel |
2020-08-31 |
| NCT01255358 |
Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients |
https://ClinicalTrials.gov/show/NCT01255358 |
Completed |
Erydel |
2011-09-30 |
| NCT01104649 |
Efficacy of Riluzole in Hereditary Cerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT01104649 |
Completed |
S. Andrea Hospital |
2014-02-28 |
| NCT01096082 |
Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3 |
https://ClinicalTrials.gov/show/NCT01096082 |
Completed |
Hospital de Clinicas de Porto Alegre |
2012-12-31 |
| NCT01016366 |
Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT01016366 |
Completed |
H. Lundbeck A/S |
2011-03-31 |
| NCT00998634 |
Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2) |
https://ClinicalTrials.gov/show/NCT00998634 |
Completed |
Federico II University |
2012-11-30 |
| NCT00993967 |
Long-Term Safety and Tolerability of Idebenone in Friedreich’s Ataxia Patients (MICONOS Extension) |
https://ClinicalTrials.gov/show/NCT00993967 |
Completed |
Santhera Pharmaceuticals |
2012-06-30 |
| NCT00992771 |
Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3 |
https://ClinicalTrials.gov/show/NCT00992771 |
Completed |
University of South Florida |
2011-04-30 |
| NCT00957216 |
Coenzyme Q10 in Adult-Onset Ataxia |
https://ClinicalTrials.gov/show/NCT00957216 |
Completed |
The University of Texas Medical Branch, Galveston |
2009-08-31 |
| NCT00950196 |
Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia |
https://ClinicalTrials.gov/show/NCT00950196 |
Completed |
Sheba Medical Center |
2009-11-30 |
| NCT00905268 |
A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich’s Ataxia (FRDA) Patients |
https://ClinicalTrials.gov/show/NCT00905268 |
Completed |
Santhera Pharmaceuticals |
2010-01-31 |
| NCT00897221 |
A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT00897221 |
Completed |
ApoPharma |
2011-03-31 |
| NCT02829268 |
A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome |
https://ClinicalTrials.gov/show/NCT02829268 |
Recruiting |
Washington University School of Medicine |
2020-12-31 |
| NCT02603926 |
Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone |
https://ClinicalTrials.gov/show/NCT02603926 |
Completed |
University of California, Davis |
2016-12-31 |
| NCT02197104 |
Citocoline for Treatment of FXTAS |
https://ClinicalTrials.gov/show/NCT02197104 |
Completed |
Rush University Medical Center |
2017-01-31 |
| NCT02103075 |
Neuromuscular Electrical Stimulation on Median Nerve Facilitates Low Motor Cortex Excitability in Human With Spinocerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT02103075 |
Completed |
Chang Gung University |
2005-10-31 |
| NCT01975909 |
Transcranial Magnetic Stimulation in Spino-Cerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT01975909 |
Completed |
Beth Israel Deaconess Medical Center |
2016-10-31 |
| NCT00824512 |
Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT00824512 |
Completed |
Ipsen |
2011-10-31 |
| NCT04192136 |
NAD+ and Exercise in FA |
https://ClinicalTrials.gov/show/NCT04192136 |
Recruiting |
Children’s Hospital of Philadelphia |
2024-12-31 |
| NCT02035020 |
A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients |
https://ClinicalTrials.gov/show/NCT02035020 |
Completed |
Azienda Policlinico Umberto I |
2014-07-30 |
| NCT00811681 |
Effect of Pioglitazone Administered to Patients With Friedreich’s Ataxia: Proof of Concept |
https://ClinicalTrials.gov/show/NCT00811681 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2013-03-31 |
| NCT03962114 |
Effects of Vitamin B3 in Patients With Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT03962114 |
Enrolling by invitation |
Radboud University |
2019-12-01 |
| NCT01962363 |
EPI-743 in Friedreich’s Ataxia Point Mutations |
https://ClinicalTrials.gov/show/NCT01962363 |
Completed |
University of South Florida |
2016-06-30 |
| NCT03286686 |
Sensori-motor and Perceptual Functions of the PPC. |
https://ClinicalTrials.gov/show/NCT03286686 |
Recruiting |
Hospices Civils de Lyon |
2024-02-22 |
| NCT03214588 |
Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT03214588 |
Completed |
Takeda |
2018-12-27 |
| NCT01035671 |
Safety and Efficacy Study of A0001 in Subjects With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT01035671 |
Completed |
Penwest Pharmaceuticals Co. |
2011-02-28 |
| NCT00697073 |
Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich’s Ataxia Patients |
https://ClinicalTrials.gov/show/NCT00697073 |
Completed |
Santhera Pharmaceuticals |
2010-05-31 |
| NCT00683943 |
Lithium Treatment for Patients With Spinocerebellar Ataxia Type I |
https://ClinicalTrials.gov/show/NCT00683943 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-02-25 |
| NCT00656409 |
Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) |
https://ClinicalTrials.gov/show/NCT00656409 |
Completed |
Institute of Child Health |
NA |
| NCT00640003 |
Baclofen Treatment of Ataxia Telangiectasia |
https://ClinicalTrials.gov/show/NCT00640003 |
Completed |
Johns Hopkins University |
2011-02-28 |
| NCT00584948 |
Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome |
https://ClinicalTrials.gov/show/NCT00584948 |
Completed |
University of California, Davis |
2012-09-30 |
| NCT00537680 |
Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT00537680 |
Completed |
Santhera Pharmaceuticals |
2009-04-30 |
| NCT00530127 |
A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT00530127 |
Completed |
ApoPharma |
2009-07-31 |
| NCT00272272 |
Fall Prevention in a Geriatric Nursing Home Setting Using the Music of Nolwenn Leroy |
https://ClinicalTrials.gov/show/NCT00272272 |
Completed |
Carrick Institute for Graduate Studies |
2006-10-31 |
| NCT00229632 |
Idebenone to Treat Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT00229632 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-12-17 |
| NCT00224640 |
Iron-Chelating Therapy and Friedreich Ataxia |
https://ClinicalTrials.gov/show/NCT00224640 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2008-03-31 |
| NCT00202397 |
Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia |
https://ClinicalTrials.gov/show/NCT00202397 |
Completed |
S. Andrea Hospital |
2008-06-30 |
| NCT00187057 |
Study for Treatment of Cancer in Children With Ataxia-telangiectasia |
https://ClinicalTrials.gov/show/NCT00187057 |
Completed |
St. Jude Children’s Research Hospital |
2006-08-31 |
| NCT02415127 |
Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT02415127 |
Completed |
Horizon Pharma Ireland, Ltd., Dublin Ireland |
2016-11-30 |
| NCT00078481 |
Phase 1 Trial of Idebenone to Treat Patients With Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT00078481 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00015808 |
Safety Study of Idebenone to Treat Friedreich’s Ataxia |
https://ClinicalTrials.gov/show/NCT00015808 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |